Prosecution Insights
Last updated: November 04, 2026
Application No. 18/920,856

DEVICE FOR SEPARATING BUBBLES FROM INJECTABLE DRUGS

Non-Final OA §102§103
Filed
Oct 19, 2024
Priority
Dec 04, 2023 — RE 10-2023-0173334
Examiner
HARRIS, WESLEY G
Art Unit
Tech Center
Assignee
Chungmed Co. Ltd.
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
545 granted / 741 resolved
+13.5% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
41 currently pending
Career history
800
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
36.8%
-3.2% vs TC avg
§102
22.9%
-17.1% vs TC avg
§112
36.4%
-3.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 741 resolved cases

Office Action

§102 §103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 7279031 B1 to Wright. Wright discloses: Regarding claim 1: A device (310) for separating bubbles (column 9, lines 44-51) from an injectable drug (“transfusate”, column 1, lines 10-15), comprising: an inlet port (328) configured to couple with a first tube (“a hose or fluid line”, column 7, lines 15-28; further interpreted as intended use since this structure is not positively claimed); an outlet port (334) configured to couple with a second tube (“a hose or fluid line”, column 7, lines 45-51; further interpreted as intended use since this structure is not positively claimed); a bubble separating portion (318/314/316) provided between the inlet port (328) and the outlet port (334), and comprising a passage cross-sectional area more enlarged than the passage cross- sectional area of the first tube (larger that the cross-sectional area of 328 which connects and mate with the first tube and therefore large than the cross-sectional area of the first tube); and a mesh portion (86) provided in a passage of the inlet port (328) or a passage of the bubble separating portion (318/314/316) (see figure 14 where 86 is located within the bubble separating portion 318). Regarding claim 2: The device of claim 1, wherein the bubble separating portion (318/314/316) comprises a spherical (see spherical shape of 318 and 18 in figure 1), ellipsoidal, or cylindrical inner space. Regarding claim 3: The device of claim 1, wherein a flow direction in the inlet port (328) and a flow direction in the outlet port (334) are parallel to each other (as shown in figure 14; column 7, lines 35-40). Regarding claim 4: The device of claim 3, wherein the bubble separating portion (318/314/316) is rotationally symmetrical with respect to a central axis in the flow direction (as shown in figure 14 where the central axis 345 is central of 318). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 5 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 7279031 B1 to Wright as applied to claim 4 above, and further in view of WO 2020223500 A1 to Hu et al. (Hu). Regarding claim 5: Wright fails to disclose: The device of claim 4, wherein the mesh portion comprises a honeycomb structure. Hu teaches: A device (23A-23B) that includes an air removal chamber (¶0172). Further, the air removal chamber includes a perforated structure that can be a mesh, honeycomb, or porous substrate (¶0172). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Wright to replace the mesh portion with a honeycomb structure as taught by Hu since Hu indicates these structures are interchangeable (Hu, ¶0172). Further, this is a simple substitution of one known element (mesh structure of Wright) for another (honeycomb structure of Hu) to obtain predictable results (to separate air from a flow of fluid). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The following is pertinent prior art: US-3631654-A Riely See the mesh 13 US-4191654-A Larson See the mesh 32 WO-2023148100-A1 FORDE See the abutment 30 GB-2495625-A CASSIDY See the abutment 22 WO-2022023079-A1 FORDE See the mesh 102 WO-9014115-A1 TSUKADA See bubble separating portion 2 Any inquiry concerning this communication or earlier communications from the examiner should be directed to WESLEY HARRIS whose telephone number is (571)272-3665. The examiner can normally be reached M to F, 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached on (571) 270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WESLEY G HARRIS/Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Oct 19, 2024
Application Filed
Oct 05, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779132
NEEDLE SHIELD REMOVER AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE NEEDLE SHIELD REMOVER
2y 11m to grant Granted Nov 03, 2026
Patent 12773237
Surgical Instrument
3y 3m to grant Granted Oct 27, 2026
Patent 12773488
OPHTHALMIC SURGICAL CASSETTE
2y 3m to grant Granted Oct 27, 2026
Patent 12766248
DISPENSING DEVICE FOR WEARABLE DRUG DELIVERY DEVICE
4y 6m to grant Granted Oct 20, 2026
Patent 12765871
TREATMENT TOOL FOR ENDOSCOPE
3y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
95%
With Interview (+21.6%)
2y 6m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 741 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month